Faiza Altaf

Faiza Altaf practices at MedStar Good Samaritan Hospital in Baltimore, Maryland, part of MedStar Health.

Faiza Altaf's NPI, 1568967552, was assigned on March 29, 2018. Faiza Altaf holds Maryland license D0091496.

Faiza Altaf's primary practice is MedStar Good Samaritan Hospital, at 5601 Loch Raven Boulevard, Baltimore, MD 21239 in Baltimore City. The practice phone is (443) 444-3902.

Faiza Altaf's primary practice is MedStar Good Samaritan Hospital in Baltimore, Maryland, part of MedStar Health. Faiza Altaf is also affiliated with MedStar Franklin Square Medical Center. The medical group on file is MedStar Medical Group. Dmand AI also links Faiza Altaf to 1 more group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Faiza Altaf practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Faiza Altaf's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Faiza Altaf is licensed in Maryland.

CMS data shows 878 Medicare services from Faiza Altaf across 3 procedure codes in 2024, for 279 Medicare patients. Medicare paid $91,914 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 279 Medicare patients who saw Faiza Altaf in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 50% are also on Medicaid. Their average risk score is 3.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Faiza Altaf's median patient age at 65, with 54% women.

In 2024, Faiza Altaf wrote 184 Medicare Part D claims for 78 patients. 91% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $169 in total drug cost. In 2023, CMS named 22 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Faiza Altaf for performance year 2024, reported as part of a group. Faiza Altaf accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Faiza Altaf from 2 drug and device companies in 2021. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $21.